Irinotecan targets actively dividing cells in your body. In
cases of cancer, this is a good thing because it stops rapidly
dividing cancer cells from growing. However, it can also affect
other tissues of your body that have high turnover rate, including
the bone marrow and epithelial lining of the intestine. Hence,
irinotecan increases the risk of diarrhea and neutropenia.